4-((((1r,4r)-4-Hydroxycyclohexyl)amino)methyl)benzonitrile

Catalog No. :
ACBIHP412
CAS No. :
1353978-09-2
Molecular Formula :
C14H18N2O
Molecular Weight :
230.31

IUPAC Name:4-((((1r,4r)-4-hydroxycyclohexyl)amino)methyl)benzonitrile

4-((((1r,4r)-4-Hydroxycyclohexyl)amino)methyl)benzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$655.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((((1r,4r)-4-Hydroxycyclohexyl)amino)methyl)benzonitrile
IUPAC Name4-((((1r,4r)-4-hydroxycyclohexyl)amino)methyl)benzonitrile
MDL No.MFCD21098568
Molecular FormulaC14H18N2O
Molecular Weight230.31
SMILESN#CC1=CC=C(CN[C@H]2CC[C@H](O)CC2)C=C1
InChI KeyHSEHAYCOUMYVKC-HDJSIYSDSA-N
Synonym(1R,4R)-4-[(4-Hydroxy-cyclohexylaMino)-Methyl]-benzonitrile;4-((((1r,4r)-4-Hydroxycyclohexyl)aMino)Methyl)benzonitrile;Benzonitrile, 4-[[(trans-4-hydroxycyclohexyl)amino]methyl]-
CAS No.1353978-09-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBIHP412 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAJMV029 route compound structure diagram
    ACAJMV029105-07-7 In Stock
  2. Plus
  3. ACNYBK268 route compound structure diagram
    ACNYBK26850910-54-8 In Stock
  4. Then
  5. ACBIHP412 route product structure diagram
    ACBIHP4121353978-09-2
Inquiry

2. ACBIHP412 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTLQ528 route compound structure diagram
    ACDTLQ52810406-25-4 In Stock
  2. Plus
  3. ACBYCA497 route compound structure diagram
    ACBYCA49713482-22-9 In Stock
  4. Then
  5. ACBIHP412 route product structure diagram
    ACBIHP4121353978-09-2
Inquiry

Comments (0)